| abstract |
A cell useful for elucidating the mechanism of insulin secretion is provided. In addition, an insulin secretion inhibitor is provided. A pancreatic β cell line that can be subcultured and secretes green fluorescent protein-labeled insulin in a glucose concentration-dependent manner is provided. Moreover, the insulin secretion inhibitor containing lithium chloride, the insulin secretion inhibitor containing glycogen synthase kinase (GSK) 3 (beta) expression inhibitor, and the insulin secretion inhibitor containing GSK3 (beta) -siRNA are provided. [Selection] Figure 2 |